Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00478894 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Multicenter Orthopaedic Outcomes Network (MOON) ACL Reconstruction (ACLR): Onsite Follow-up

Study acronym: MOON-Onsite
StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Trial status: Active, Not Recruiting to Completedv18
  2. Notable Primary completion date: Dec 2024 to Dec 2025 Study sites: 3 to 4v17 Show 1 more changeShow less
    • Study sites: 3 to 4
  3. Notable Primary completion date: Dec 2023 to Dec 2024 Completion date: Dec 2024 to Dec 2025 · Eligibility criteria shortened, about 12 wordsv16 Show 2 more changesShow less
    • Completion date: Dec 2024 to Dec 2025
    • Eligibility criteria shortened, about 12 words

    See this version in full on ClinicalTrials.gov ↗

  4. Minor Re-verified, no change to tracked fieldsv15
  5. Notable Primary completion date: Dec 2021 to Dec 2023 Completion date: Dec 2022 to Dec 2024v14 Show 1 more changeShow less
    • Completion date: Dec 2022 to Dec 2024
Show 12 earlier versionsHide 12 earlier versions
  1. Minor Primary completion date: Jul 2021 to Dec 2021 Completion date: Dec 2021 to Dec 2022v13 Show 1 more changeShow less
    • Completion date: Dec 2021 to Dec 2022
  2. Minor Trial status: Enrolling by Invitation to Active, Not Recruiting Study sites: 4 to 3v12 Show 1 more changeShow less
    • Study sites: 4 to 3
  3. Notable Primary completion date: Jul 2020 to Jul 2021 Completion date: Dec 2020 to Dec 2021v11 Show 1 more changeShow less
    • Completion date: Dec 2020 to Dec 2021
  4. Minor Re-verified, no change to tracked fieldsv10
  5. Notable Lead sponsor: Vanderbilt University Medical Center to Vanderbilt Universityv9
  6. Notable Lead sponsor: Vanderbilt University to Vanderbilt University Medical Centerv8
  7. Notable Primary completion date: Dec 2014 to Jul 2020 Enrollment target: estimated 400 to confirmed 432 · Completion date: Dec 2014 to Dec 2020 · Study title revised · 1 morev7 Show 4 more changesShow less
    • Enrollment target: estimated 400 to confirmed 432
    • Completion date: Dec 2014 to Dec 2020
    • Study title revised
    • Study description expanded, about 2 words

    See this version in full on ClinicalTrials.gov ↗

  8. Minor Primary completion date: Dec 2014 Completion date: Aug 2014 to Dec 2014 · Eligibility criteria expanded, about 21 words · Study description expanded, about 7 wordsv6 Show 3 more changesShow less
    • Completion date: Aug 2014 to Dec 2014
    • Eligibility criteria expanded, about 21 words
    • Study description expanded, about 7 words

    See this version in full on ClinicalTrials.gov ↗

  9. Minor Re-verified, no change to tracked fieldsv5
  10. Minor Enrollment target: 300 to 400 Study sites: 3 to 4 · Completion date: Aug 2010 to Aug 2014 · Collaborators: 1 to 2 · 1 morev4 Show 4 more changesShow less
    • Study sites: 3 to 4
    • Completion date: Aug 2010 to Aug 2014
    • Collaborators: 1 to 2
    • Publications: 2 to 3

    See this version in full on ClinicalTrials.gov ↗

  11. Minor Trial status: Recruiting to Enrolling by Invitation Site details revised at 3 of 3 sitesv3 Show 1 more changeShow less
    • Site details revised at 3 of 3 sites
  12. Notable Trial status: Not Yet Recruiting to Recruiting Start date: Jul 2007 to Aug 2007 · Site details revised at 3 of 3 sites · Eligibility criteria expanded, about 4 wordsv2 Show 3 more changesShow less
    • Start date: Jul 2007 to Aug 2007
    • Site details revised at 3 of 3 sites
    • Eligibility criteria expanded, about 4 words

    See this version in full on ClinicalTrials.gov ↗

  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In this study we will examine patients who have undergone unilateral ACL reconstruction surgery to determine which structural and functional characteristics of the knee two and ten years post reconstruction surgery, aspects of the original injury and repair, and patient characteristics are risk factors for osteoarthritis after ACL reconstruction surgery.
Trial Details
NCT Number NCT00478894
Lead Sponsor Vanderbilt University
Collaborators: National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Conditions Rupture of Anterior Cruciate Ligament, Osteoarthritis
Enrollment 432 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov